CTRI/2024/02/062280尚未招募3 期
Comparison of Efficacy and Safety of Subcutaneousversus Intramuscular Autologous Serum Therapy in Chronic SpontaneousUrticaria – A Randomized Controlled Study - NI
Mythraye B0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients of age above 18 years clinically diagnosed
- •with chronic spontaneous urticaria and giving consent to participate in the
排除标准
- •Pregnant and lactating women, immunocompromised
- •patients, those on immunosuppressants for other illness
研究者
相似试验
招募中
Unknown
Evaluation of Efficacy and Safety of subcutaneous Remsima injection in Subjetcs with Active Ankylosing SpondylitisDiseases of the musculoskeletal system and connective tissueKCT0008747CHONNAM NATIONAL UNIVERSITY BITGOEUL HOSPITA60
Enrolling By Invitation
不适用
Comparison of the clinical efficacy of subcutaneous versus oral administration of methotrexate in patients with psoriasis vulgarispsoriasis vulgaris,methotrexate,psoriasis vulgarisoral administration,subcutaneous injectionTCTR20190705002Faculty of Medicine80
尚未招募
2 期
ESAR-814 StudyRheumatoid arthritis with moderate activityArthritis, RheumatoidArthritisJoint DiseasesRheumatic DiseasesMusculoskeletal DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesRPCEC00000230Center for Genetic Engineering and Biotechnology (CIGB), in Havana196
未知
3 期
Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis (STATURE)JPRN-jRCT2080221733ovartis Pharma K.K.
已完成
不适用
To evaluate the efficacy and safety of subcutaneous and intravenous abatacept.Rheumatoid arthritisJPRN-UMIN000013440Osaka Medical College50